Export 3 results:
Author Title Type [ Year(Desc)]
Filters: Author is Sundaramurthy, Varadharajan  [Clear All Filters]
2021
Prabhakara C, Godbole R, Sil P, Jahnavi S, Gulzar S-E-J, van Zanten TS, Sheth D, Subhash N, Chandra A, Shivaraj A, Panikulam P, U I, Nuthakki VKumar, Puthiyapurayil TParassini, Ahmed R, Najar AHussain, Lingamallu SManoz, Das S, Mahajan B, Vemula P et al..  2021.  Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors.. PLoS Pathog. 17(7):e1009706. DOI:10.1371/journal.ppat.1009706.
2023
Bhatt T, Dam B, Khedkar SUday, Lall S, Pandey S, Kataria S, Ajnabi J, Gulzar S-E-J, Dias PM, Waskar M, Raut J, Sundaramurthy V, Vemula PKumar, Ghatlia N, Majumdar A, Jamora C.  2023.  Niacinamide enhances cathelicidin mediated SARS-CoV-2 membrane disruption.. Front Immunol. 14:1255478. DOI:10.3389/fimmu.2023.1255478.
2024
Asokan MS, Joan RFlorina, Babji S, Dayma G, Nadukkandy P, Subrahmanyam V, Pandey A, Malagi G, Arya P, Mahajan V, Bhavikatti J, Pawar K, Thorat A, Shah P, Goud RB, Roy B, Rajukutty S, Immanuel S, Agarwal D, Saha S et al..  2024.  Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study.. Lancet Reg Health Southeast Asia. 22:100361. DOI:10.1016/j.lansea.2024.100361.